Key facts
- It has raised $500K; the latest was Seed Round in Sep 2025.
- Notable investors include Plug and Play Tech Center, National Institutes of Health, Innosphere Ventures, Boulder, Boulder Angels — 12 tracked in total.
- Status: Privately Held (backing).
Investors
12+- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Kioga
- ·The full record, as it builds
Funding rounds
No funding rounds for Kioga are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kioga
Operator of a biotechnology company intended to address the gut-brain connection and improve outcomes related to stress, metabolic challenges, and depression. The company offers an approach to health and wellness by utilizing its proprietary postbiotic technology, which employs heat-killed bacterial strains that deliver stable and consistent benefits through its bioactive components, addressing the complete biological pathway from gut to brain, enabling clients to improve overall well-being.
- Sector
- Healthcare
- HQ
- Boulder, CO, United States
- Founded
- 2018
- Employees
- 3
- Website
- kioga.bio/
- Ownership
- Privately Held (backing)
Kioga doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kioga shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kioga in its N-PORT filings yet. We sweep new filings monthly.